Рет қаралды 7,788
The panelists, Adam Brufsky, MD; Sara Hurvitz, MD; Hope Rugo, MD; Joyce O’Shaughnessy, MD; and Christy Russell, MD, assess the role of estrogen receptor (ER) antagonist, fulvestrant, in metastatic hormone receptor-positive breast cancer.